[Federal Register Volume 88, Number 91 (Thursday, May 11, 2023)]
[Notices]
[Pages 30316-30317]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-10069]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the Advisory Committee on Infant and Maternal 
Mortality (Formerly the Advisory Committee on Infant Mortality)

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

[[Page 30317]]

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Advisory Committee on Infant and Maternal 
Mortality (ACIMM or Committee) has scheduled a public meeting. 
Information about ACIMM and the agenda for this meeting can be found on 
the ACIMM website at https://www.hrsa.gov/advisory-committees/infant-mortality/index.html.

DATES: June 13, 2023, 10:00 a.m. to 5:00 p.m. Eastern Time and June 14, 
2023, 9:30 a.m. to 2:00 p.m. Eastern Time.

ADDRESSES: This meeting will be conducted in-person at HRSA 
Headquarters, 5600 Fishers Lane, Conference Room 5N54, Rockville, MD 
20857. The meeting will also be held via webinar. The webinar link and 
log-in information will be available at ACIMM's website before the 
meeting: https://www.hrsa.gov/advisory-committees/infant-mortality/index.html.

FOR FURTHER INFORMATION CONTACT: Vanessa Lee, MPH, Designated Federal 
Official, Maternal and Child Health Bureau, HRSA, 5600 Fishers Lane, 
Room 18N84, Rockville, Maryland 20857; 301-443-0543; or [email protected].

SUPPLEMENTARY INFORMATION: ACIMM is authorized by section 222 of the 
Public Health Service Act (42 U.S.C. 217a), as amended and governed by 
provisions of Public Law 92-463, as amended (5 U.S.C. 10), which sets 
forth standards for the formation and use of Advisory Committees.
    ACIMM advises the Secretary of Health and Human Services 
(Secretary) on department activities, partnerships, policies, and 
programs directed at reducing infant mortality, maternal mortality and 
severe maternal morbidity, and improving the health status of infants 
and women before, during, and after pregnancy. The Committee provides 
advice on how to coordinate federal, state, local, tribal, and 
territorial governmental efforts designed to improve infant mortality, 
related adverse birth outcomes, maternal health, as well as influence 
similar efforts in the private and voluntary sectors. The Committee 
provides guidance and recommendations on the policies, programs, and 
resources required to address the disparities and inequities in infant 
mortality, related adverse birth outcomes and maternal health outcomes, 
including maternal mortality and severe maternal morbidity. With its 
focus on underlying causes of the disparities and inequities seen in 
birth outcomes for women and infants, ACIMM advises the Secretary on 
the health, social, economic, and environmental factors contributing to 
the inequities and proposes structural, policy, and/or systems level 
changes.
    The agenda for the June 13-14, 2023, meeting is being finalized and 
may include the following topics: an update on the recommendations 
submitted to the Secretary on improving birth outcomes among American 
Indian and Alaska Native mothers and infants; further discussion to 
determine new and continuing priority areas for the Committee, 
including data and information related to social determinants of health 
and infant health equity; federal updates; and Committee operations. 
Agenda items are subject to change as priorities dictate. Refer to the 
ACIMM website listed above for any updated information concerning the 
meeting.
    Members of the public will have the opportunity to provide written 
or oral comments. Requests to submit a written statement or make oral 
comments to ACIMM should be sent to Vanessa Lee, using the email 
address above at least 3 business days prior to the meeting. Public 
participants may submit written statements in advance of the scheduled 
meeting by emailing [email protected]. Oral comments will be honored in 
the order they are requested and may be limited as time allows.
    Individuals who plan to attend and need special assistance or a 
reasonable accommodation should notify Vanessa Lee at the contact 
information listed above at least 10 business days prior to the 
meeting. Since this meeting occurs in a federal government building, 
attendees must go through a security check to enter the building. Non-
U.S. Citizen attendees must notify HRSA of their planned attendance at 
least 20 business days prior to the meeting in order to facilitate 
their entry into the building. All attendees are required to present 
government-issued identification prior to entry.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023-10069 Filed 5-10-23; 8:45 am]
BILLING CODE 4165-15-P